top of page
Search


Gabriel Korn
Apr 20, 20231 min read
UroPharma is moving rapidly to commercialisation. The science and momentum are with us.
We are now moving into the MANUFACTURING STAGE, going through the pre-launch regulatory processes and distributors have been identified....
54 views
0 comments


Gabriel Korn
Mar 10, 20231 min read
New opportunities in bladder treatments.
As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration...
32 views
0 comments


Gabriel Korn
Feb 7, 20232 min read
New Bladder therapies to ease the suffering of millions by simply changing clinical practice.
UroPharma’s dtb-Instilla Intermittent will: aid the fight against anti-microbial resistance, Urinary Tract Infections and address the...
36 views
0 comments

Gabriel Korn
Nov 25, 20221 min read
Benefits of Direct-to-Bladder drug targeting.
Quality of Life is a priority for healthcare professionals. Direct-to-Bladder therapies by UroPharma go a long way towards achieving best...
11 views
0 comments
bottom of page